These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 16453004

  • 1. JAK2 V617F mutation, PRV-1 overexpression and endogenous erythroid colony formation show different coexpression patterns among Ph-negative chronic myeloproliferative disorders.
    Bellosillo B, Besses C, Florensa L, Solé F, Serrano S.
    Leukemia; 2006 Apr; 20(4):736-7. PubMed ID: 16453004
    [No Abstract] [Full Text] [Related]

  • 2. The effect of the JAK2 V617F mutation on PRV-1 expression.
    Mnjoyan Z, Yoon D, Li J, Delhommeau F, Afshar-Kharghan V.
    Haematologica; 2006 Mar; 91(3):411-2. PubMed ID: 16503546
    [Abstract] [Full Text] [Related]

  • 3. A quantitative assay for JAK2(V617F) mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis.
    Vannucchi AM, Pancrazzi A, Bogani C, Antonioli E, Guglielmelli P.
    Leukemia; 2006 Jun; 20(6):1055-60. PubMed ID: 16572198
    [Abstract] [Full Text] [Related]

  • 4. Inconsistencies in the association between the JAK2(V617F) mutation and PRV-1 over-expression among the chronic myeloproliferative diseases.
    Vannucchi AM, Guglielmelli P, Antonioli E, Mappa S, Pancrazzi A, Bogani C, Ponziani V, Bosi A.
    Br J Haematol; 2006 Mar; 132(5):652-4; author reply 654. PubMed ID: 16445842
    [No Abstract] [Full Text] [Related]

  • 5. Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia.
    Tefferi A, Sirhan S, Lasho TL, Schwager SM, Li CY, Dingli D, Wolanskyj AP, Steensma DP, Mesa R, Gilliland DG.
    Br J Haematol; 2005 Oct; 131(2):166-71. PubMed ID: 16197445
    [Abstract] [Full Text] [Related]

  • 6. [Not just another kinase. New knowledge about myeloproliferative disease].
    Bjerrum OW.
    Ugeskr Laeger; 2006 Sep 25; 168(39):3293. PubMed ID: 17032590
    [No Abstract] [Full Text] [Related]

  • 7. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
    Teofili L, Giona F, Martini M, Cenci T, Guidi F, Torti L, Palumbo G, Amendola A, Foà R, Larocca LM.
    J Clin Oncol; 2007 Mar 20; 25(9):1048-53. PubMed ID: 17369568
    [Abstract] [Full Text] [Related]

  • 8. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
    Michiels JJ, De Raeve H, Berneman Z, Van Bockstaele D, Hebeda K, Lam K, Schroyens W.
    Semin Thromb Hemost; 2006 Jun 20; 32(4 Pt 2):307-40. PubMed ID: 16810609
    [Abstract] [Full Text] [Related]

  • 9. The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients.
    Goerttler PS, Steimle C, März E, Johansson PL, Andreasson B, Griesshammer M, Gisslinger H, Heimpel H, Pahl HL.
    Blood; 2005 Oct 15; 106(8):2862-4. PubMed ID: 15985544
    [Abstract] [Full Text] [Related]

  • 10. JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders.
    Rossi D, Deambrogi C, Capello D, Cerri M, Lunghi M, Parvis G, Saglio G, Gaidano G, Cilloni D.
    Br J Haematol; 2006 Oct 15; 135(2):267-8. PubMed ID: 16956348
    [No Abstract] [Full Text] [Related]

  • 11. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ, Bernema Z, Van Bockstaele D, De Raeve H, Schroyens W.
    Pathol Biol (Paris); 2007 Mar 15; 55(2):92-104. PubMed ID: 16919893
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic assays for the JAK2 V617F mutation in chronic myeloproliferative disorders.
    Greiner TC.
    Am J Clin Pathol; 2006 May 15; 125(5):651-3. PubMed ID: 16707363
    [No Abstract] [Full Text] [Related]

  • 13. Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders.
    McClure R, Mai M, Lasho T.
    Leukemia; 2006 Jan 15; 20(1):168-71. PubMed ID: 16270039
    [No Abstract] [Full Text] [Related]

  • 14. [A recurrent mutation of the JAK2 gene in chronic myeloproliferative disorders].
    Berger R.
    Pathol Biol (Paris); 2006 May 15; 54(4):182-4. PubMed ID: 16084028
    [No Abstract] [Full Text] [Related]

  • 15. [New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene].
    Larsen TS, Pallisgaard N, Christensen JH, Gram-Hansen P, Kerndrup GB, Møller MB, Hasselbalch HC.
    Ugeskr Laeger; 2006 Sep 25; 168(39):3295-9. PubMed ID: 17032591
    [Abstract] [Full Text] [Related]

  • 16. [New molecular markers within the chronic myeloproliferative disorders. II: the JAK2 mutation].
    Larsen TS, Pallisgaard N, Christensen JH, Gram-Hansen P, Kerndrup GB, Møller MB, Hasselbalch HC.
    Ugeskr Laeger; 2006 Sep 25; 168(39):3299-303. PubMed ID: 17032592
    [Abstract] [Full Text] [Related]

  • 17. JAK2 V617F mutation in classic chronic myeloproliferative diseases: a report on a series of 349 patients.
    Vizmanos JL, Ormazábal C, Larráyoz MJ, Cross NC, Calasanz MJ.
    Leukemia; 2006 Mar 25; 20(3):534-5. PubMed ID: 16408096
    [No Abstract] [Full Text] [Related]

  • 18. New insights into the pathogenesis of JAK2 V617F-positive myeloproliferative disorders and consequences for the management of patients.
    Villeval JL, James C, Pisani DF, Casadevall N, Vainchenker W.
    Semin Thromb Hemost; 2006 Jun 25; 32(4 Pt 2):341-51. PubMed ID: 16810610
    [Abstract] [Full Text] [Related]

  • 19. JAK2 V617F: a single mutation in the myeloproliferative group of disorders.
    McLornan D, Percy M, McMullin MF.
    Ulster Med J; 2006 May 25; 75(2):112-9. PubMed ID: 16755940
    [No Abstract] [Full Text] [Related]

  • 20. The V617F JAK2 mutation and the myeloproliferative disorders.
    Percy MJ, McMullin MF.
    Hematol Oncol; 2005 May 25; 23(3-4):91-3. PubMed ID: 16285006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.